These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19950789)

  • 1. Multicenter phase II study of FOLFOX for metastatic colorectal cancer (mCRC) in Japan; SWIFT-1 and 2 study.
    Nagata N; Kondo K; Kato T; Shibata Y; Okuyama Y; Ikenaga M; Tanemura H; Oba K; Nakao A; Sakamoto J; Mishima H
    Hepatogastroenterology; 2009; 56(94-95):1346-53. PubMed ID: 19950789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
    Fuse N; Doi T; Ohtsu A; Takeuchi S; Kojima T; Taku K; Tahara M; Muto M; Asaka M; Yoshida S
    Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
    Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
    Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study.
    Berretta M; Cappellani A; Fiorica F; Nasti G; Frustaci S; Fisichella R; Bearz A; Talamini R; Lleshi A; Tambaro R; Cocciolo A; Ristagno M; Bolognese A; Basile F; Meneguzzo N; Berretta S; Tirelli U
    Arch Gerontol Geriatr; 2011; 52(1):89-93. PubMed ID: 20211502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study.
    Kato T; Nagata N; Fujii M; Takemoto H; Kondo K; Okuyama Y; Tominaga H; Sakamoto J; Mishima H
    Anticancer Res; 2011 Dec; 31(12):4657-64. PubMed ID: 22199346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
    Figer A; Perez-Staub N; Carola E; Tournigand C; Lledo G; Flesch M; Barcelo R; Cervantes A; André T; Colin P; Louvet C; de Gramont A
    Cancer; 2007 Dec; 110(12):2666-71. PubMed ID: 17963264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and efficacy analysis of FOLFOX4 regimen in elderly compared to younger colorectal cancer patients].
    Kuboki Y; Ichimura T; Ogura M; Matsuda M; Suenaga M; Shinozaki E; Matsuzaka S; Chin K; Mizunuma N; Hatake K
    Gan To Kagaku Ryoho; 2008 May; 35(5):781-5. PubMed ID: 18487913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].
    Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Kataoka J; Hori S; Nasu J; Imamine S; Iguchi H
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2249-53. PubMed ID: 18079624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.
    Scalamogna R; Brugnatelli S; Tinelli C; Sagrada P; Gattoni E; Tronconi MC; Riccardi A; Luchena G; Corazza GR
    Oncology; 2007; 72(5-6):267-73. PubMed ID: 18187947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.
    Boku N; Ohtsu A; Hyodo I; Shirao K; Miyata Y; Nakagawa K; Tamura T; Hatake K; Tanigawara Y
    Jpn J Clin Oncol; 2007 Jun; 37(6):440-5. PubMed ID: 17656482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.
    des Guetz G; Mariani P; Cucherousset J; Benamoun M; Lagorce C; Sastre X; Le Toumelin P; Uzzan B; Perret GY; Morere JF; Breau JL; Fagard R; Schischmanoff PO
    Anticancer Res; 2007; 27(4C):2715-9. PubMed ID: 17695437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy.
    Huang MY; Huang ML; Chen MJ; Lu CY; Chen CF; Tsai PC; Chuang SC; Hou MF; Lin SR; Wang JY
    Pharmacogenet Genomics; 2011 Jan; 21(1):18-25. PubMed ID: 21057378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience.
    Shimizu T; Satoh T; Tamura K; Ozaki T; Okamoto I; Fukuoka M; Nakagawa K
    Int J Clin Oncol; 2007 Jun; 12(3):218-23. PubMed ID: 17566846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
    Shibata M; Shimura T; Nishina Y; Gonda K; Matsuo S; Abe H; Yajima Y; Nakamura I; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2011 May; 38(5):797-801. PubMed ID: 21566440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modified FOLFOX6(mFOLFOX6)in metastatic colorectal carcinoma patients with poor performance status].
    Nishi T; Hamamoto Y; Uemoto J; Onodera K; Warita E; Yamanaka Y
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2557-60. PubMed ID: 23235179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
    Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
    Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic metastatectomy of colorectal cancer following mFOLFOX6 treatment--analysis of 7 cases].
    Okada N; Ishibashi K; Yokoyama M; Kuwabara K; Hatano S; Ishii M; Kubota S; Chika N; Tamaru J; Miyazaki T; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2028-31. PubMed ID: 20037313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.